MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Morphological changes of retina in patients with Parkinson’s disease and the role of α-synuclein in retinal damage

    L. Man, Z. Wei (Chengdu, China)

    Objective: To analyze the characteristics of retinal structural changes in patients with PD by the noninvasive technology of OCT. Demonstrate the role of α-syn in pathological changes of…
  • MDS Virtual Congress 2020

    Researches on the correlation between wearable device data and UPDRS scores in patients with Parkinson’s disease

    B.o Shen (Nanjing, China)

    Objective: To collect spatiotemporal parameter information of motor symptoms in patients with Parkinson's disease (PD) using wearable device, and analyze its correlation with the Unified…
  • MDS Virtual Congress 2020

    Real-World Data on the Use of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson’s Disease who are Treated with Deep Brain Stimulation: The PD-DUAL Study

    J. Aldred, F. Amjad, A. Johnson, P. Kukreja, I. Malaty, S. Parashos, J. Siddiqui, M. Siddiqui, J. Zamudio, S. Thakkar (Spokane, WA, USA)

    Objective: To examine the use of oral anti-parkinsonian medications in advanced Parkinson’s disease (APD) patients who have a history of, or current treatment with deep…
  • MDS Virtual Congress 2020

    Monitoring electrophysiological recordings in patients with LCIJ therapy

    D. Gunal, H. Ozden, S. Irmak, K. Uluc (Istanbul, Turkey)

    Objective: Levodopa carbidopa intestinal jel (LCIJ) treatment for advanced Parkinson’s disease patients is live-saving for the appropriate patients, however follow up of the patients has…
  • MDS Virtual Congress 2020

    Low dose Cabergoline for freezing of gait in advanced Parkinson’s disease – you can have your cake and eat it too!

    N. Sharma, A. Kumari, N. Sawal, H. Singh, K. Shukla (Chandigarh, India)

    Objective: To evaluate efficacy of cabergoline for treating FOG in advanced IPD. Background: FOG is a major cause of disability in advanced IPD. FOG responds…
  • MDS Virtual Congress 2020

    Photophobia and Progressive Supranuclear Palsy

    K. Hay, D. Mohanty, Y. Lin, H. Kang, J. Sellers-Gibson, D. Claassen (Nashville, TN, USA)

    Objective: To characterize the prevalence, symptoms, and severity of light sensitivity in Progressive Supranuclear palsy (PSP)). Background: Photophobia is a commonly encountered clinical symptom in…
  • MDS Virtual Congress 2020

    Long and short survival in Parkinson syndrome: pathology and genetics are key prognostic factors

    A. Rajput, C. Robinson, M. Farrer, E. Gustavsson, A. Rajput (Saskatoon, SK, Canada)

    Objective: To study the clinical, pathological and genetic profile of Parkinson syndrome (PS) cases that have > 20 years survival (long survival, or LS) compared…
  • MDS Virtual Congress 2020

    Clinical progression of Parkinson’s disease: insights from the NINDS common data elements

    M. Lewis, E. Harkins, E. Lee, C. Stetter, B. Snyder, T. Corson, G. Du, L. Kong, X. Huang (Hershey, PA, USA)

    Objective: To synchronize data collection, the National Institute of Neurological Disorders and Stroke recommended Common Data Elements (CDEs) for use in Parkinson’s disease (PD) research.…
  • MDS Virtual Congress 2020

    Music-based interventions for the management of movement disorders: a systematic literature review

    S. Saade-Lemus, J. Martin-Saavedra, A. Deik (Philadelphia, PA, USA)

    Objective: To conduct a systematic review of the current evidence regarding the use of music-based interventions for the management of patients with movement disorders. Background:…
  • MDS Virtual Congress 2020

    POLR3A Leukodystrophy presenting with levodopa responsive parkinsonism

    K. Kyle, J. Bronstein, Y. Bordelon (Los Angeles, CA, USA)

    Objective: This is a case of a 51-year-old lady with POLR3A related leukodystrophy and secondary dopa responsive parkinsonism. Background: Neurologic symptoms began 15 years ago…
  • « Previous Page
  • 1
  • …
  • 97
  • 98
  • 99
  • 100
  • 101
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley